Rosetta Genomics (Israel)
Rosetta Genomics Ltd. was a molecular diagnostics company with offices in Israel and the United States that uses micro-ribonucleic acid biomarkers to develop diagnostic tests designed to differentiate between various types of cancer. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Rosetta Genomics (Israel), Israel, covering academic research published from 2002 to 2020. Read More.
Open Access Percentage
42%
Total
Publications
97
Total Open
Publications
41
Total
Citations
13K
Open Access
Percentage
42%
Total
Publications
97
Total Open
Publications
41
Total
Citations
13K
Breakdown
Publisher Open
19%
Both
22%
Other Platform Open
2%
Closed
57%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 48%
19
Hybrid 15%
6
No Guarantees 37%
15
Other Platform Open
Other Internet 78%
18
Domain 30%
7
Public 9%
2
Institution 4%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
DOI | Other Internet | 18 |
PubMed Central | Domain | 6 |
Figshare | Public | 2 |
National Institutes of Health | Institution | 1 |
Europe PMC | Domain | 1 |